Author

William F. Elmquist

University of MinnesotaORCID 0000-0002-7478-3429Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Brandon A. WilbanksiD· 1 shared Caroline D. DohertyiD· 1 shared Danielle M. BurgenskeiD· 1 shared Jann Nagina SarkariaiD· 1 shared Jeffrey A. Meridew· 1 shared Jessica I. G. GriffithiD· 1 shared Katie Bakken· 1 shared Keenan S. PearsoniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Brandon A. WilbanksORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

In Vivo Selection of anti-glioblastoma DNA aptamer-drug conjugates in an orthotopic patient-derived xenograft model

Caroline D. Doherty, Sonia Jain, Lauren L. Ott, Katie Bakken, Brandon A. Wilbanks, Danielle M. Burgenske, Keenan S. Pearson, Jessica I. G. Griffith, Zichen Tian, Jeffrey A. Meridew, Saigopalakrishna S. Yerneni, William F. Elmquist, Jann Nagina Sarkaria, Louis James Maher III

This study develops and tests DNA aptamer-drug conjugates (ApDCs) for glioblastoma treatment using an in vivo SELEX approach in a patient-derived xenograft model.

NAR Cancer · Jul 27, 2026Peer-reviewedCancer Biology